Advertisement
Original article| Volume 60, ISSUE 6, P563-569, September 15, 2006

Tryptophan Hydroxylase-1 Gene Variants Associated with Schizophrenia

      Background

      Serotonin (5-HT) has been implicated in the pathophysiology of schizophrenia. Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in the biosynthesis of serotonin (5-HT), and as such it might be related to the pathogenesis of schizophrenia. Two isoforms are known, TPH-1 and TPH-2. TPH-1 association with schizophrenia is debated.

      Methods

      A case-control design was employed for gene-disease association in 155 schizophrenic psychosis patients and 253 healthy controls, all North European Caucasians. Six single nucleotide polymorphisms (SNPs) with a haplotype block structure spanning over 23 kb of the total TPH-1 29 kb were analyzed. Linkage disequilibrium and haplotype analyses were performed. Bonferroni correction was used for multiple testing.

      Results

      Single marker association analyses showed two SNPs significantly associated with schizophrenia. Several haplotypes were associated with the disease. A “sliding window” analysis attributed the strongest disease association to a haplotype configuration localized between the promoter region and intron 3.

      Conclusions

      Our data indicate that TPH-1 associates with schizophrenia. It appears that specific combinations of promoter variants vis-à-vis gene transcript variants contribute to genetic predisposition to the disease.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aghajanian G.K.
        Electrophysiological studies on the actions of hallucinogenic drugs at 5-HT2 receptors in rat brain.
        NIDA Res Monogr. 1994; 146: 183-202
        • American Psychiatric Association
        Diagnostic and Statistical manual of mental disorders. 3rd Edition, revised. American Psychiatric Association, Washington, DC1987
        • Arango V.
        • Huang Y.Y.
        • Underwood M.D.
        • Mann J.J.
        Genetics of the serotonergic system in suicidal behavior.
        J Psychiatr Res. 2003; 37: 375-386
        • Breier A.
        Serotonin, schizophrenia and antipsychotic drug action.
        Schizophr Res. 1995; 14: 187-202
        • Cardon L.R.
        • Bell J.I.
        Association study designs for complex diseases.
        Nat Rev Genet. 2001; 2: 91-99
        • Chao H.M.
        • Richardson M.A.
        Aromatic amino acid hydroxylase genes and schizophrenia.
        Am J Med Genet. 2002; 114: 626-630
        • Chaouloff F.
        Physiopharmacological interactions between stress hormones and central serotonergic systems.
        Brain Res Brain Res Rev. 1993; 18: 1-32
        • Chotai J.
        • Serretti A.
        • Lorenzi C.
        Interaction between the tryptophan hydroxylase gene and the serotonin transporter gene in schizophrenia but not in bipolar or unipolar affective disorders.
        Neuropsychobiology. 2005; 51: 3-9
        • Clark A.G.
        The role of haplotypes in candidate gene studies.
        Genet Epidemiol. 2004; 27: 321-333
        • Cooper J.R.
        • Melcer I.
        The enzymic oxidation of tryptophan to 5-hydroxytryptophan in the biosynthesis of serotonin.
        J Pharmacol Exp Ther. 1961; 132: 265-268
        • Courtet P.
        • Jollant F.
        • Castelnau D.
        • Buresi C.
        • Malafosse A.
        Suicidal behavior: relationship between phenotype and serotonergic genotype.
        Am J Med Genet C Semin Med Genet. 2005; 133: 25-33
        • Craddock N.
        • O’Donovan M.C.
        • Owen M.J.
        The genetics of schizophrenia and bipolar disorder: dissecting psychosis.
        J Med Genet. 2005; 42: 193-204
        • Craig S.P.
        • Boularand S.
        • Darmon M.C.
        • Mallet J.
        • Craig I.W.
        Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3----p14 by in situ hybridization.
        Cytogenet Cell Genet. 1991; 56: 157-159
        • De Luca V.
        • Voineskos D.
        • Wong G.W.
        • Shinkai T.
        • Rothe C.
        • Strauss J.
        • et al.
        Promoter polymorphism of second tryptophan hydroxylase isoform (TPH2) in schizophrenia and suicidality.
        Psychiatry Res. 2005; 134: 195-198
        • Gabriel S.B.
        • Schaffner S.F.
        • Nguyen H.
        • Moore J.M.
        • Roy J.
        • Blumenstiel B.
        • et al.
        The structure of haplotype blocks in the human genome.
        Science. 2002; 296: 2225-2229
        • Geijer T.
        • Frisch A.
        • Persson M.L.
        • Wasserman D.
        • Rockah R.
        • Michaelovsky E.
        • et al.
        Search for association between suicide attempt and serotonergic polymorphisms.
        Psychiatr Genet. 2000; 10: 19-26
        • Gizatullin R.
        • Zaboli G.
        • Jonsson E.G.
        • Asberg M.
        • Leopardi R.
        Haplotype Analysis Reveals Tryptophan Hydroxylase (TPH) 1 Gene Variants Associated with Major Depression.
        Biol Psychiatry. 2006; 59: 295-300
        • Graeff F.G.
        Role of 5-HT in defensive behavior and anxiety.
        Rev Neurosci. 1993; 4: 181-211
        • Gurevich E.V.
        • Joyce J.N.
        Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.
        Biol Psychiatry. 1997; 42: 529-545
        • Gustavsson J.P.
        • Nothen M.M.
        • Jonsson E.G.
        • Neidt H.
        • Forslund K.
        • Rylander G.
        • et al.
        No association between serotonin transporter gene polymorphisms and personality traits.
        Am J Med Genet. 1999; 88: 430-436
        • Hoehe M.R.
        Haplotypes and the systematic analysis of genetic variation in genes and genomes.
        Pharmacogenomics. 2003; 4: 547-570
        • Hong C.J.
        • Tsai S.J.
        • Wang Y.C.
        Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders.
        Schizophr Res. 2001; 49: 59-63
        • Hughes C.
        • Kumari V.
        • Soni W.
        • Das M.
        • Binneman B.
        • Drozd S.
        • et al.
        Longitudinal study of symptoms and cognitive function in chronic schizophrenia.
        Schizophr Res. 2003; 59: 137-146
        • Iqbal N.
        • van Praag H.M.
        The role of serotonin in schizophrenia.
        Eur Neuropsychopharmacol. 1995; 5: 11-23
        • Jonsson E.G.
        • Goldman D.
        • Spurlock G.
        • Gustavsson J.P.
        • Nielsen D.A.
        • Linnoila M.
        • et al.
        Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
        Eur Arch Psychiatry Clin Neurosci. 1997; 247: 297-302
        • Jonsson E.G.
        • Norton N.
        • Forslund K.
        • Mattila-Evenden M.
        • Rylander G.
        • Asberg M.
        • et al.
        Association between a promoter variant in the monoamine oxidase A gene and schizophrenia.
        Schizophr Res. 2003; 61: 31-37
        • Joyce J.N.
        • Shane A.
        • Lexow N.
        • Winokur A.
        • Casanova M.F.
        • Kleinman J.E.
        Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
        Neuropsychopharmacology. 1993; 8: 315-336
        • Judson R.
        • Stephens J.C.
        • Windemuth A.
        The predictive power of haplotypes in clinical response.
        Pharmacogenomics. 2000; 1: 15-26
        • Lieberman J.A.
        • Mailman R.B.
        • Duncan G.
        • Sikich L.
        • Chakos M.
        • Nichols D.E.
        • et al.
        Serotonergic basis of antipsychotic drug effects in schizophrenia.
        Biol Psychiatry. 1998; 44: 1099-1117
        • Lohmueller K.E.
        • Pearce C.L.
        • Pike M.
        • Lander E.S.
        • Hirschhorn J.N.
        Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.
        Nat Genet. 2003; 33: 177-182
        • Mann J.J.
        • Malone K.M.
        • Nielsen D.A.
        • Goldman D.
        • Erdos J.
        • Gelernter J.
        Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients.
        Am J Psychiatry. 1997; 154: 1451-1453
        • Meltzer H.Y.
        Role of serotonin in the action of atypical antipsychotic drugs.
        Clin Neurosci. 1995; 3: 64-75
        • Meltzer H.Y.
        The role of serotonin in antipsychotic drug action.
        Neuropsychopharmacology. 1999; 21: 106S-115S
        • Mowry B.J.
        • Nancarrow D.J.
        Molecular genetics of schizophrenia.
        Clin Exp Pharmacol Physiol. 2001; 28: 66-69
        • Nielsen D.A.
        • Jenkins G.L.
        • Stefanisko K.M.
        • Jefferson K.K.
        • Goldman D.
        Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7.
        Brain Res Mol Brain Res. 1997; 45: 145-148
        • Nielsen D.A.
        • Virkkunen M.
        • Lappalainen J.
        • Eggert M.
        • Brown G.L.
        • Long J.C.
        • et al.
        A tryptophan hydroxylase gene marker for suicidality and alcoholism.
        Arch Gen Psychiatry. 1998; 55: 593-602
        • Nolan K.A.
        • Volavka J.
        • Lachman H.M.
        • Saito T.
        An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorder.
        Psychiatr Genet. 2000; 10: 109-115
        • O’Donovan M.C.
        • Williams N.M.
        • Owen M.J.
        Recent advances in the genetics of schizophrenia.
        Hum Mol Genet. 2003; 12 (Spec No 2): R125-R133
        • Paik I.
        • Toh K.
        • Kim J.
        • Lee C.
        TPH gene may be associated with suicidal behavior, but not with schizophrenia in the Korean population.
        Hum Hered. 2000; 50: 365-369
        • Prasad S.
        • Semwal P.
        • Deshpande S.
        • Bhatia T.
        • Nimgaonkar V.L.
        • Thelma B.K.
        Molecular genetics of schizophrenia: past, present and future.
        J Biosci. 2002; 27: 35-52
        • Riedel W.J.
        • Sobczak S.
        • Schmitt J.A.
        Tryptophan modulation and cognition.
        Adv Exp Med Biol. 2003; 527: 207-213
        • Rotondo A.
        • Schuebel K.
        • Bergen A.
        • Aragon R.
        • Virkkunen M.
        • Linnoila M.
        • et al.
        Identification of four variants in the tryptophan hydroxylase promoter and association to behavior.
        Mol Psychiatry. 1999; 4: 360-368
        • Rund B.R.
        • Melle I.
        • Friis S.
        • Larsen T.K.
        • Midboe L.J.
        • Opjordsmoen S.
        • et al.
        Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis.
        Am J Psychiatry. 2004; 161: 466-472
        • Schotte A.
        • Janssen P.F.
        • Gommeren W.
        • Luyten W.H.
        • Van Gompel P.
        • Lesage A.S.
        • et al.
        Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
        Psychopharmacology (Berl). 1996; 124: 57-73
        • Sekizawa T.
        • Iwata Y.
        • Nakamura K.
        • Matsumoto H.
        • Suzuki A.
        • Suzuki K.
        • et al.
        Childhood-onset schizophrenia and tryptophan hydroxylase gene polymorphism.
        Am J Med Genet B Neuropsychiatr Genet. 2004; 128: 24-26
        • Semwal P.
        • Prasad S.
        • Bhatia T.
        • Deshpande S.N.
        • Wood J.
        • Nimgaonkar V.L.
        • et al.
        Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia.
        Mol Psychiatry. 2001; 6: 220-224
        • Semwal P.
        • Prasad S.
        • Varma P.G.
        • Bhagwat A.M.
        • Deshpande S.N.
        • Thelma B.K.
        Candidate gene polymorphisms among North Indians and their association with schizophrenia in a case-control study.
        J Genet. 2002; 81: 65-71
        • Serretti A.
        • Lilli R.
        • Lorenzi C.
        • Lattuada E.
        • Cusin C.
        • Smeraldi E.
        Tryptophan hydroxylase gene and major psychoses.
        Psychiatry Res. 2001; 103: 79-86
        • Shinkai T.
        • Ohmori O.
        • Suzuki T.
        • Kojima H.
        • Hori H.
        • Terao T.
        • et al.
        Polymorphisms of tryptophan hydroxylase gene and the symptomatology of schizophrenia: an association study.
        Psychiatr Genet. 2000; 10: 165-171
        • Skodol A.E.
        • Siever L.J.
        • Livesley W.J.
        • Gunderson J.G.
        • Pfohl B.
        • Widiger T.A.
        The borderline diagnosis II: biology, genetics, and clinical course.
        Biol Psychiatry. 2002; 51: 951-963
        • Sodhi M.S.
        • Sanders-Bush E.
        Serotonin and brain development.
        Int Rev Neurobiol. 2004; 59: 111-174
        • Spitzer R.L.
        • Williams J.B.
        • Gibbon M.
        • First M.B.
        The Structured Clinical Interview for DSM-III-R (SCID).
        Arch Gen Psychiatry. 1992; 49: 624-629
        • Sumiyoshi T.
        • Stockmeier C.A.
        • Overholser J.C.
        • Dilley G.E.
        • Meltzer H.Y.
        Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia.
        Brain Res. 1996; 708: 209-214
        • Walther D.J.
        • Bader M.
        A unique central tryptophan hydroxylase isoform.
        Biochem Pharmacol. 2003; 66: 1673-1680
        • Westenberg H.G.
        Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?.
        J Affect Disord. 1996; 40: 85-93
        • Whitaker-Azmitia P.M.
        • Borella A.
        • Raio N.
        Serotonin depletion in the adult rat causes loss of the dendritic marker MAP-2.
        Neuropsychopharmacology. 1995; 12: 269-272
        • Whitaker-Azmitia P.M.
        • Shemer A.V.
        • Caruso J.
        • Molino L.
        • Azmitia E.C.
        Role of high affinity serotonin receptors in neuronal growth.
        Ann N Y Acad Sci. 1990; 600: 315-330
        • Zill P.
        • Baghai T.C.
        • Zwanzger P.
        • Schule C.
        • Eser D.
        • Rupprecht R.
        • et al.
        SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression.
        Mol Psychiatry. 2004; 9: 1030-1036
        • Zill P.
        • Buttner A.
        • Eisenmenger W.
        • Bondy B.
        • Ackenheil M.
        Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains.
        Eur Neuropsychopharmacol. 2004; 14: 282-284